Cambridge, United Kingdom

Josquin Nys

This inventor holds 1 USPTO granted patent and 1 published patent application. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Josquin Nys

Introduction

Josquin Nys is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of therapeutic binding molecules. His work focuses on innovative solutions for treating diseases related to the chemokine receptor CCR9.

Latest Patents

One of Josquin Nys's key patents is centered around therapeutic binding molecules. This invention relates to antibodies that specifically bind to the chemokine receptor CCR9. The patent addresses the treatment of CCR9-mediated diseases, particularly inflammatory bowel disease (IBD). Additionally, it includes methods for detecting CCR9 using the binding molecules developed by Nys.

Career Highlights

Throughout his career, Josquin Nys has demonstrated a commitment to advancing medical science through his inventions. His work has the potential to significantly impact the treatment of various inflammatory conditions. The innovative nature of his research showcases his dedication to improving patient outcomes.

Collaborations

Josquin has collaborated with esteemed colleagues, including Albert George Thom and Peter Cariuk. These partnerships have contributed to the development and refinement of his inventions.

Conclusion

Josquin Nys is a pioneering inventor whose work on therapeutic binding molecules represents a significant advancement in the treatment of CCR9-mediated diseases. His contributions to medical science are noteworthy and have the potential to improve the lives of many individuals suffering from inflammatory conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…